The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it none, with a mean price target of $18.
ARMOUR Residential REIT, Inc.
ARR · the NYSE · USD · Market cap $2.3B
ARMOUR Residential REIT, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-07
Screened 2026-09-07 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
ARMOUR Residential REIT, Inc. holds its Markdown at $16.35. The statistical read favours the sellers, held for 2 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 2 days |
| Price at the screen | $16.35 |
| Valuation | 3.71 trailing · 5.57 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.34 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: mortgage
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: mortgage | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 16.2% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMortgage REITs Look Cheap But Ethics Block Us
Picture a homeowner in Florida whose monthly payment gets sliced up and sold as a bond. ARMOUR Residential REIT sits in the middle of that chain, buying government-backed mortgage securities for an 88% profit margin and 20% return on equity. The numbers look attractive on a 5.6 times forward earnings multiple with a 16% gap to stated fair value, yet we pass outright because the business sits in a sector our ethical screen rejects on principle.
The low multiple and analyst buy ratings reflect a classic mortgage REIT profile that can deliver high yields when rates cooperate. However, these vehicles are inherently cyclical, exposed to interest-rate swings and housing-market turns that can turn peak earnings into sharp reversals without warning.
Risk sits in the ethical failure plus leverage and prepayment volatility that can erode book value quickly. The opportunity rating stays at none for these reasons. Analysis, not advice.
| Forward P/E | 5.6xvery cheap relative to earnings |
| Trailing P/E | 3.7xvery cheap relative to earnings |
| EPS, trailing | 4.41 |
| EPS, forward | 2.93 |
| Profit margin | 87.8%highly profitable on every dollar of sales |
| Return on equity | 20.3%an exceptional return on shareholder capital |
| Dividend yield | 1,684.00% |
| Debt to equity | 7.57heavy leverage: higher risk if revenue softens |
| Current ratio | 1.14adequate liquidity, worth monitoring |
| Beta | 1.34moves a little more than the market |
| Short interest, float | 0.00% |
| 52-week range | 13.98 - 19.31 |
| Market cap | $2.3B |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeARR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it none, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it none, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (4 analysts) rates it none, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-24 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-14 | Kevin Hern | Republican | sell | 1K–15K |
| 2026-08-14 | Kevin Hern | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $17.48 | -3.0% | $0.24 | $983 | -1.7% |
| 2 months | $17.19 | -1.4% | $0.48 | $1,014 | +1.4% |
| 3 months | $16.70 | +1.5% | $0.72 | $1,058 | +5.8% |
| 6 months | $15.62 | +8.5% | $1.44 | $1,177 | +17.7% |
| 1 year | $14.10 | +20.2% | $2.88 | $1,406 | +40.6% |
| 2 years | $13.94 | +21.6% | $5.76 | $1,629 | +62.9% |
| 3 years | $15.26 | +11.0% | $9.76 | $1,750 | +75.0% |
| 5 years | $26.09 | -35.1% | $21.46 | $1,472 | +47.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ARR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.